Esoteric Anatomic Pathology Testing Is Goal of New Pact between PAML and CellNetix

Agreement calls for both parties to collaborate in offering esoteric and reference anatomic pathology services nationally

It is an effort to align their clinical laboratory and anatomic pathology  services to the evolving needs of hospitals, physicians and other providers. To achieve this goal, two laboratory organizations in the Pacific Northwest finalized months of negotiations and inked an agreement that involves an equity investment and the creation of a new esoteric anatomic pathology collaboration.

Yesterday, PAML, LLC, of Spokane, Washington, and CellNetix, based in Seattle, Washington, announced that PAML had completed a minority investment in the technical laboratory business division owned by CellNetix. The two companies also stated that they entered into an agreement to work together to form a “jointly owned national Esoteric Anatomic Pathology reference laboratory offering.” (more…)

Mayo Medical Laboratories Enters Pathology Testing Agreement with China’s Kindstar

Mayo Clinic to support one of China’s largest clinical laboratory companies

In a trans-Pacific Ocean collaboration with major implications, two important players in clinical laboratory and anatomic pathology  testing in their respective countries have inked a multi-year pact. On June 27, 2011, Mayo Clinic of Rochester, Minnesota, announced its agreement with Wuhan Kindstar Globalgene Technology, Inc. (Kindstar), of Wuhan, Hubei Province, China.

In the press release it issued about the agreement, Mayo Clinic said that it would support Kindstar by providing “specialized laboratory support based on provision of knowledge from Mayo Clinic’s Department of Laboratory Medicine and Pathology and its reference laboratory, Mayo Medical Laboratories.” Mayo Clinic also said that it will receive equity in Kindstar and had participated in Kindstar’s Series B financing, which raised approximately U.S. $11 million.

PAML and Centura Health Announce Creation of New Clinical Pathology Laboratory Company in Denver

It’s the second new hospital laboratory joint venture for PAML in past eight days

Earlier today, PAML and Centura Health of Denver, Colorado, announced the creation of a new clinical pathology laboratory company. It will be called “Colorado Laboratory Services” (CLS) and will operate as an LLC (limited liability company). CLS represents the second major hospital laboratory outreach joint venture for PAML in the past eight days.

Centura Health is Colorado’s largest integrated health system. It owns 13 hospitals and its flagship is 593-bed St. Anthony Central Hospital in Denver. Its hospitals are strategically located throughout the Denver metropolitan area and will provide CLS with a local presence to serve physicians’ offices located around each of these medical campuses.